
Cellbricks
A tissue therapeutics company – built on DeepTech innovation – offering a scalable solution to restore lost tissue and organ function for millions of patients.
Seed ·
Amount not disclosed in a source on record.
Funding history ↓Signals
Website registeredNov 12, 2024 (2 years old)
Funding rounds
- Seed · amount undisclosedSource: fundraisingfox.com
- Website created
Founders and team
AL
Alexander Leutner Co-CEO (Business) & Co-foundersource: cellbricks-therapeutics.comTL
Tobias Lam CTO & Co-foundersource: cellbricks-therapeutics.comAT
Alexander Thomas Soft Tissue Program Lead & Co-foundersource: cellbricks-therapeutics.com
Companies like Cellbricks
LLUCA Science$30M Series B+ · Jun 2022
RReCode TherapeuticsSeries B+ · Oct 2023SScience$230M Series B+ · Mar 2026
LLucina BiotherapeuticsSeed · Aug 2026
CCellbricks Therapeutics$11.59M Seed · Mar 2026
FFrontier Bio
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/cellbricks (get a free API key).